for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Miraca Holdings Inc.

4544.T

Latest Trade

2,704.00JPY

Change

-21.00(-0.77%)

Volume

41,800

Today's Range

2,702.00

 - 

2,742.00

52 Week Range

2,228.00

 - 

3,170.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2,725.00
Open
2,740.00
Volume
41,800
3M AVG Volume
4.53
Today's High
2,742.00
Today's Low
2,702.00
52 Week High
3,170.00
52 Week Low
2,228.00
Shares Out (MIL)
56.98
Market Cap (MIL)
155,577.30
Forward P/E
23.35
Dividend (Yield %)
4.80

Next Event

Q3 2020 Miraca Holdings Inc Earnings Release

Latest Developments

More

Miraca Holdings To Buy All Shares Of Tokyo-Based Selmesta

R&I affirms Miraca Holdings's rating at "A" and says stable outlook

Fujirebio Says Entered Into Agreement With Janssen Pharmaceuticals

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Miraca Holdings Inc.

Miraca Holdings Inc. is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and healthcare related business. The Company operates in three business segments. The Clinical Diagnostic segment is engaged in the manufacture and sale of clinical diagnostics. The Entrusted Clinical Examination segment is involved in entrusted clinical examinations from medical institutions. The Healthcare segment is engaged in the provision of sterilization services and clinical trial services, as well as the rental of nursing care products.

Industry

Healthcare Facilities

Contact Info

Shinjuku Mitsui Bldg.

2-1-1, Nishishinjuku

+81.3.59093335

https://www.miraca.com/

Executive Leadership

Shigekazu Takeuchi

Representative Executive Officer, President, Group Chief Executive Officer, Director

Naoki Kitamura

Chief Financial Officer, Executive Officer, Chairman & Chief Executive Officer of Subsidiaries, Director

Yoshihiro Ashihara

Executive Officer, President of Subsidiary

Tadashi Hasegawa

Executive Officer, Chief Director of Planning Administration

Shunichi Higashi

Executive Officer, President of Subsidiary

Key Stats

3.00 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.2K

2018

0.2K

2019

0.2K

2020(E)

0.2K
EPS (JPY)

2017

5.840

2018

4.510

2019

111.939

2020(E)

116.124
Price To Earnings (TTM)
34.69
Price To Sales (TTM)
0.84
Price To Book (MRQ)
1.40
Price To Cash Flow (TTM)
10.29
Total Debt To Equity (MRQ)
39.54
LT Debt To Equity (MRQ)
25.57
Return on Investment (TTM)
3.01
Return on Equity (TTM)
2.27

Latest News

Latest News

BRIEF-Morpho says capital alliance with Miraca Holdings

* Says it plans to issue 100,800 shares of its common stock to Miraca Holdings Inc to raise 499.7 million yen via capital alliance, with payment date of Dec. 7

BRIEF- Miraca Holdings to offer early-retirement program

* Says the employees who take up the offer will retire on Jan. 31, 2018

BRIEF-Miraca Holdings says business transfer between two units

* Says a Tokyo-based wholly owned unit FRHD will take over the subsidiary management business from its unit FUJIREBIO Inc., on July 1

BRIEF-R&I affirms Miraca Holdings's rating at "A" and says stable outlook-R&I

* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A"-R&I

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up